COVID-19 'precautionary' vaccine: Appointments for third dose to open today; check details here

-

Appointments for the ‘precautionary dose’ of the COVID-19 vaccine in India will begin today, 8 January, according to the announcement made by the central government. The Centre has also said that no new registrations in the CoWin platform would be required for those taking the shot. The health ministry will release the schedules for vaccination on Saturday.

The three priority groups of healthcare workers, frontline workers and 60-plus population with comorbidities, who are eligible for their third “precautionary dose” 39 weeks after getting their second jab, can either book an online appointment or walk into any vaccination centre, sources in the Ministry of Health and Family Welfare said on Friday.

“Those who have taken two doses of COVID-19 vaccine can directly take an appointment or walk into any vaccination centre,” the Union health ministry said.

It added that online appointment facility would also start by Saturday evening. Vaccination with on-site appointment starts on 10 January.

From 10 January, India will start administering the precautionary dose of the vaccine to healthcare workers, frontline workers and those above 60 years of age with comorbidities.

Amid concerns for a third wave and the emergence of the Omicron variant, Prime Minister Narendra Modi had on 25 December announced the Centre’s decision to administer a ‘precautionary dose’ of the vaccine.

The Centre has already notified the states and Union territories that for each recipient, the third dose would be the same shot that was used for the first two doses.

Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram



from Firstpost India Latest News https://ift.tt/3qZU3FW
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more